Pramlintide Therapy, Chapter 11 – Part 1 Steve V. Edelman, MD Robert R. Henry, MD The discovery of insulin over 80 years ago is one of the great success stories in the history of modern medicine. Although insulin remains the mainstay of therapy for many patients with diabetes, the greatest …
Read More »Diagnosis and Management of Type 2 Diabetes, 10th Edition, Ch 11-Pt 2
Pramlintide Therapy Steve V. Edelman, MD Robert R. Henry, MD Mechanisms of Action: Gastric Emptying In healthy individuals, amylin modulates the rate of gastric emptying, most likely via the vagus nerve, to regulate the inflow of nutrients into the small intestine and thereby reduce the postprandial rise in glucose.
Read More »Diagnosis and Management of Type 2 Diabetes, Tenth Edition
Insulin Therapy, Chapter 9 – Part 1 Steve V. Edelman, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego Robert R. Henry, MD, Professor of Medicine, Division of Endocrinology and Metabolism, University of California, San Diego Insulin therapy most commonly is reserved for patients …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.